Dr. Alan S. Boyd, M.D.
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical Branch at Galveston (1986)
- Years since graduation
- 40
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 663
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1986Medical school: University of Texas Medical Branch at Galveston
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
TN license 024611 -
Dermatopathology Physician
TN license 024611
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Vanderbilt University Medical Center Nashville, TN
- Vanderbilt Bedford Hospital Shelbyville, TN
Medical groups
- Vanderbilt University Medical Center (3,567 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 663
- Services billed
- 2,514
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 420 | 81 |
| Biopsy of related skin growth, first growth | 318 | 245 |
| Established patient office or other outpatient visit, 10-19 minutes | 202 | 166 |
| Biopsy of related skin growth, each additional growth | 170 | 89 |
| Established patient office or other outpatient visit, 20-29 minutes | 165 | 126 |
| Destruction of precancer skin growth, 1 growth | 142 | 116 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 128 | 23 |
| Destruction of precancer skin growth, 15 or more growths | 73 | 57 |
| New patient office or other outpatient visit, 15-29 minutes | 66 | 66 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 51 | 36 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Triamcinolone Acetonide Other prescribers in Nashville, TN | 53 |
| Clobetasol Propionate Other prescribers in Nashville, TN | 40 |
| Methotrexate (methotrexate sodium) Other prescribers in Nashville, TN | 21 |
| Minocycline Hcl Other prescribers in Nashville, TN | 21 |
| Mycophenolate Mofetil Other prescribers in Nashville, TN | 19 |
| Acitretin | 19 |
| Ketoconazole Other prescribers in Nashville, TN | 18 |
| Metronidazole Other prescribers in Nashville, TN | 16 |
| Fluocinonide Other prescribers in Nashville, TN | 14 |
| Fluocinolone Acetonide (fluocinolone/shower cap) | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.